Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2012

Feb 23, 2012

29875_dirs_2012-02-23_f25b35d2-60e7-450b-a349-b3d2db418969.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2012-02-22

Reporting Person: Bisaccia Lisa (SVP, Chief HR Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-22 Common Stock M 11987 $30.035 Acquired 15577 Direct
2012-02-22 Common Stock S 11987 $43.67 Disposed 3590 Direct
2012-02-22 Common Stock M 10706 $28.10 Acquired 14296 Direct
2012-02-22 Common Stock S 10706 $43.67 Disposed 3590 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-22 Stock Option $30.035 M 11987 Disposed 2013-04-03 Common Stock (11987) Direct
2012-02-22 Stock Option $28.10 M 10706 Disposed 2016-04-01 Common Stock (10706) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock (restricted) 26247.0004 Direct
ESOP Common Stock 541.7254 Indirect
Stock Unit 22568.0016 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Phantom Stock Credits $1.00 Common Stock (473.7955) 473.7955 Direct
Stock Option $20.21 2014-09-08 Common Stock (0) 0 Direct
Stock Option $34.42 2014-04-03 Common Stock (11341) 11341 Direct
Stock Option $41.17 2015-04-01 Common Stock (13838) 13838 Direct
Stock Option $36.23 2017-04-01 Common Stock (45897) 45897 Direct
Stock Option $34.96 2018-04-01 Common Stock (48230) 48230 Direct

Footnotes

F1: Represents weighted average sale price for this trading day. Multiple sales ere executed, with sales prices ranging between $43.66 and $43.69 per share.

F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $43.66 and $43.69 per share.

F3: Option became exercisable in three equal annual installments, commencing 4/3/2007.

F4: Option became exercisable in three equal annual installments, commencing 4/1/2010.

F5: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, as such time as has been elected by the reporting person.

F6: Remaining option became exercisable in three equal installments on 9/8/2007.

F7: Option became exercisable in three equal annual installments, commencing 4/2/2008

F8: Option became exercisable in three equal annual installments, commencing 4/1/2009.

F9: Option became exercisable in three equal annual installments, commencing 4/1/2011.

F10: Option becomes exercisable in four equal annual installments, commencing 4/1/2012.